Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)

Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)

In this episode, Rob and Greg are joined by guest Andy Ruskin, healthcare attorney and government payer expert from K&L Gates. They’ll be discussing the 2026 CMS OPPS Final Rule, focusing on the provision related to the ODACS, or Outpatient Drug Acquisition Cost Survey. They’ll review the statutory landscape surrounding the survey, recap past attempts by CMS to lower 340B hospital reimbursement, and discuss considerations for hospitals as they contemplate how to respond this time around.

In the intro, the guys review updates to manufacturer 340B policies. Specifically, they discuss a new policy from one manufacturer that conditions 340B pricing access for in-house pharmacies on claim submission requirements.

Jaksot(91)

Ep 85 | HRSA Information Collection Request – 340B Enrollment, Registration & Recertification

Ep 85 | HRSA Information Collection Request – 340B Enrollment, Registration & Recertification

In this episode, Greg and Rob are joined again by healthcare attorney Emily Cook. They discuss a recent HRSA Information Collection Request (ICR) that describes some changes being made to the 340B enr...

2 Helmi 58min

Ep 83 | 340B Rebates Are on Hold

Ep 83 | 340B Rebates Are on Hold

In this episode, Greg and Rob share some initial reactions around the recent judicial activity affecting HRSA's 340B rebate model. They'll discuss thoughts on the federal court ruling that halted the ...

12 Tammi 27min

Ep 82 | Recap of 340B Developments from 2025

Ep 82 | Recap of 340B Developments from 2025

In this episode, Greg and Rob recap key developments in the 340B space from 2025.  They’ll discuss the flurry of activity in recent months related to 340B rebates, project the impact of the OBBB on DS...

22 Joulu 202545min

Ep 81 | 340B Rebate Q&A with Beacon

Ep 81 | 340B Rebate Q&A with Beacon

In this episode, Greg and Rob are joined by Katheryne Richardson of the Beacon team, to discuss frequently asked questions about the upcoming 340B rebate model.  They’ll cover the differences between ...

8 Joulu 20251h 19min

Ep 80 |  340B Updates, including CMS CY26 OPPS Final Rule and Rebate Developments

Ep 80 | 340B Updates, including CMS CY26 OPPS Final Rule and Rebate Developments

In this episode, Greg and Rob catch up on some clarifications gained around the upcoming 340B rebate model, including purchasing requirements and developments with select chain retail pharmacies updat...

1 Joulu 202547min

Ep 79 | 340B Rebate Model Update

Ep 79 | 340B Rebate Model Update

In this episode, Greg and Rob share initial reactions to the HRSA update on 340B rebate model implementation. They’ll review the communication provided by HRSA on October 30th on their website, as wel...

3 Marras 202552min

Ep 78 |  Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion

Ep 78 | Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion

In this episode, Greg and Rob chat about what the government shutdown might mean for 340B Program oversight in the short-term. They’ll also discuss a flurry of developments from manufacturers recently...

13 Loka 202533min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-rahamania
ostan-asuntoja-podcast
rahapuhetta
inderespodi
rss-h-asselmoilanen
rss-lahtijat
rss-bisnesta-bebeja
herrasmieshakkerit
rss-neuvottelija-sami-miettinen
pomojen-suusta
rss-porssipuhetta
rss-laakispodi
rss-startup-ministerio
rss-paasipodi
sijoituspodi
asuntoasiaa-paivakirjat